Anti-PD-1 Antibody Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Type (Monoclonal, Polyclonal); Application (Immunohistochemistry-Paraffin (IHC-P), Immunocytochemistry (ICC), Western Blotting, Flow Cytometry, ELISA) and Geography

Report Code: TIPRE00008159 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

The anti-PD-1 antibody binds to and hinders PD-1 and the downstream signaling pathways. And may restore immune function using the activation of T-cells and cell-mediated immune responses against tumor or cancerous cells. So, the PD-1 inhibitors and PD-L1 inhibitors are a collection of checkpoint inhibitors being produced for the treatment of cancer.

MARKET DYNAMICS

The anti-PD-1 antibody market is anticipated to grow in the forecast period owing to the rising prevalence of cancer, favorable reimbursement policies, and the increasing prevalence of atrial fibrillation. Moreover, expanding investments in R&D by the biotechnology sector and growing government initiatives to create cancer awareness are also offering opportunities in market growth during the forecast period.

MARKET SCOPE

The "Global Anti-PD-1 Antibody Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of anti-PD-1 antibody market with detailed market segmentation by type, application, and geography. The global anti-PD-1 antibody market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading anti-PD-1 antibody market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global anti-PD-1 antibody market is segmented on the basis of type and application. Based on type, the market is segmented into monoclonal and polyclonal. Based on application, the market is segmented into immunohistochemistry-paraffin (IHC-P), immunocytochemistry (ICC), western blotting, flow cytometry, and ELISA.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global anti-PD-1 antibody market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anti-PD-1 antibody market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting anti-PD-1 antibody market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anti-PD-1 antibody market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the anti-PD-1 antibody market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from anti-PD-1 antibody market are anticipated to lucrative growth opportunities in the future with the rising demand for anti-PD-1 antibody market in the global market. Below mentioned is the list of few companies engaged in the anti-PD-1 antibody market.

The report also includes the profiles of key anti-PD-1 antibody market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Bio X Cell
  •  Ono Pharmaceutical Co., Ltd
  •  BioVision Inc.
  •  Thermo Fisher Scientific, Inc.
  •  Merck KGaA
  •  InvivoGen
  •  Chugai Pharmaceutical Co., Ltd
  •  Bristol-Myers Squibb
  •  Abcam Plc.
  •  Arcus Biosciences

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anti-PD-1 Antibody Market - By Type
1.3.2 Anti-PD-1 Antibody Market - By Application
1.3.3 Anti-PD-1 Antibody Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS


3. RESEARCH METHODOLOGY


4. ANTI-PD-1 ANTIBODY MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ANTI-PD-1 ANTIBODY MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. ANTI-PD-1 ANTIBODY MARKET - GLOBAL MARKET ANALYSIS

6.1. ANTI-PD-1 ANTIBODY - GLOBAL MARKET OVERVIEW
6.2. ANTI-PD-1 ANTIBODY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. ANTI-PD-1 ANTIBODY MARKET - REVENUE AND FORECASTS TO 2027 - TYPE

7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MONOCLONAL
7.3.1. Overview
7.3.2. Monoclonal Market Forecast and Analysis
7.4. POLYCLONAL
7.4.1. Overview
7.4.2. Polyclonal Market Forecast and Analysis

8. ANTI-PD-1 ANTIBODY MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION

8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. IMMUNOHISTOCHEMISTRY-PARAFFIN (IHC-P)
8.3.1. Overview
8.3.2. Immunohistochemistry-Paraffin (IHC-P) Market Forecast and Analysis
8.4. IMMUNOCYTOCHEMISTRY (ICC)
8.4.1. Overview
8.4.2. Immunocytochemistry (ICC) Market Forecast and Analysis
8.5. WESTERN BLOTTING
8.5.1. Overview
8.5.2. Western Blotting Market Forecast and Analysis
8.6. FLOW CYTOMETRY
8.6.1. Overview
8.6.2. Flow Cytometry Market Forecast and Analysis
8.7. ELISA
8.7.1. Overview
8.7.2. ELISA Market Forecast and Analysis

9. ANTI-PD-1 ANTIBODY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

9.1. NORTH AMERICA
9.1.1 North America Anti-PD-1 Antibody Market Overview
9.1.2 North America Anti-PD-1 Antibody Market Forecasts and Analysis
9.1.3 North America Anti-PD-1 Antibody Market Forecasts and Analysis - By Type
9.1.4 North America Anti-PD-1 Antibody Market Forecasts and Analysis - By Application
9.1.5 North America Anti-PD-1 Antibody Market Forecasts and Analysis - By Countries
9.1.5.1 United States Anti-PD-1 Antibody Market
9.1.5.1.1 United States Anti-PD-1 Antibody Market by Type
9.1.5.1.2 United States Anti-PD-1 Antibody Market by Application
9.1.5.2 Canada Anti-PD-1 Antibody Market
9.1.5.2.1 Canada Anti-PD-1 Antibody Market by Type
9.1.5.2.2 Canada Anti-PD-1 Antibody Market by Application
9.1.5.3 Mexico Anti-PD-1 Antibody Market
9.1.5.3.1 Mexico Anti-PD-1 Antibody Market by Type
9.1.5.3.2 Mexico Anti-PD-1 Antibody Market by Application
9.2. EUROPE
9.2.1 Europe Anti-PD-1 Antibody Market Overview
9.2.2 Europe Anti-PD-1 Antibody Market Forecasts and Analysis
9.2.3 Europe Anti-PD-1 Antibody Market Forecasts and Analysis - By Type
9.2.4 Europe Anti-PD-1 Antibody Market Forecasts and Analysis - By Application
9.2.5 Europe Anti-PD-1 Antibody Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Anti-PD-1 Antibody Market
9.2.5.1.1 Germany Anti-PD-1 Antibody Market by Type
9.2.5.1.2 Germany Anti-PD-1 Antibody Market by Application
9.2.5.2 France Anti-PD-1 Antibody Market
9.2.5.2.1 France Anti-PD-1 Antibody Market by Type
9.2.5.2.2 France Anti-PD-1 Antibody Market by Application
9.2.5.3 Italy Anti-PD-1 Antibody Market
9.2.5.3.1 Italy Anti-PD-1 Antibody Market by Type
9.2.5.3.2 Italy Anti-PD-1 Antibody Market by Application
9.2.5.4 Spain Anti-PD-1 Antibody Market
9.2.5.4.1 Spain Anti-PD-1 Antibody Market by Type
9.2.5.4.2 Spain Anti-PD-1 Antibody Market by Application
9.2.5.5 United Kingdom Anti-PD-1 Antibody Market
9.2.5.5.1 United Kingdom Anti-PD-1 Antibody Market by Type
9.2.5.5.2 United Kingdom Anti-PD-1 Antibody Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Anti-PD-1 Antibody Market Overview
9.3.2 Asia-Pacific Anti-PD-1 Antibody Market Forecasts and Analysis
9.3.3 Asia-Pacific Anti-PD-1 Antibody Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Anti-PD-1 Antibody Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Anti-PD-1 Antibody Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Anti-PD-1 Antibody Market
9.3.5.1.1 Australia Anti-PD-1 Antibody Market by Type
9.3.5.1.2 Australia Anti-PD-1 Antibody Market by Application
9.3.5.2 China Anti-PD-1 Antibody Market
9.3.5.2.1 China Anti-PD-1 Antibody Market by Type
9.3.5.2.2 China Anti-PD-1 Antibody Market by Application
9.3.5.3 India Anti-PD-1 Antibody Market
9.3.5.3.1 India Anti-PD-1 Antibody Market by Type
9.3.5.3.2 India Anti-PD-1 Antibody Market by Application
9.3.5.4 Japan Anti-PD-1 Antibody Market
9.3.5.4.1 Japan Anti-PD-1 Antibody Market by Type
9.3.5.4.2 Japan Anti-PD-1 Antibody Market by Application
9.3.5.5 South Korea Anti-PD-1 Antibody Market
9.3.5.5.1 South Korea Anti-PD-1 Antibody Market by Type
9.3.5.5.2 South Korea Anti-PD-1 Antibody Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Anti-PD-1 Antibody Market Overview
9.4.2 Middle East and Africa Anti-PD-1 Antibody Market Forecasts and Analysis
9.4.3 Middle East and Africa Anti-PD-1 Antibody Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Anti-PD-1 Antibody Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Anti-PD-1 Antibody Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Anti-PD-1 Antibody Market
9.4.5.1.1 South Africa Anti-PD-1 Antibody Market by Type
9.4.5.1.2 South Africa Anti-PD-1 Antibody Market by Application
9.4.5.2 Saudi Arabia Anti-PD-1 Antibody Market
9.4.5.2.1 Saudi Arabia Anti-PD-1 Antibody Market by Type
9.4.5.2.2 Saudi Arabia Anti-PD-1 Antibody Market by Application
9.4.5.3 U.A.E Anti-PD-1 Antibody Market
9.4.5.3.1 U.A.E Anti-PD-1 Antibody Market by Type
9.4.5.3.2 U.A.E Anti-PD-1 Antibody Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Anti-PD-1 Antibody Market Overview
9.5.2 South and Central America Anti-PD-1 Antibody Market Forecasts and Analysis
9.5.3 South and Central America Anti-PD-1 Antibody Market Forecasts and Analysis - By Type
9.5.4 South and Central America Anti-PD-1 Antibody Market Forecasts and Analysis - By Application
9.5.5 South and Central America Anti-PD-1 Antibody Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Anti-PD-1 Antibody Market
9.5.5.1.1 Brazil Anti-PD-1 Antibody Market by Type
9.5.5.1.2 Brazil Anti-PD-1 Antibody Market by Application
9.5.5.2 Argentina Anti-PD-1 Antibody Market
9.5.5.2.1 Argentina Anti-PD-1 Antibody Market by Type
9.5.5.2.2 Argentina Anti-PD-1 Antibody Market by Application

10. INDUSTRY LANDSCAPE

10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. ANTI-PD-1 ANTIBODY MARKET, KEY COMPANY PROFILES

11.1. BIO X CELL
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ONO PHARMACEUTICAL CO., LTD.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BIOVISION INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. THERMO FISHER SCIENTIFIC, INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. MERCK KGAA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. INVIVOGEN
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. CHUGAI PHARMACEUTICAL CO., LTD
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. BRISTOL-MYERS SQUIBB
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. ABCAM PLC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ARCUS BIOSCIENCES
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX

12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Bio X Cell
2. Ono Pharmaceutical Co., Ltd
3. BioVision Inc.
4. Thermo Fisher Scientific, Inc.
5. Merck KGaA
6. InvivoGen
7. Chugai Pharmaceutical Co., Ltd
8. Bristol-Myers Squibb
9. Abcam Plc.
10. Arcus Biosciences
TIPRE00008159
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking